Overview
Vanessa Johnson is a Hematologist Oncology specialist and a Palliative Medicine provider in Norwich, Connecticut. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Porphyria. Her top areas of expertise are Breast Cancer, Iron Deficiency Anemia, Paget Disease of the Breast, and Lung Cancer.
Her clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Washington St, Suite 220, Norwich, CT 06360
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale University
Alfred Lee is a Hematologist in New Haven, Connecticut. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Venous Thromboembolism (VTE), Shwartzman Phenomenon, Antiphospholipid Syndrome, Splenectomy, and Bone Marrow Aspiration.
The Hospital Of Central Connecticut At New Britain General And Bradley
Brian Byrne is a Hematologist Oncology specialist and a Hematologist in New Britain, Connecticut. Dr. Byrne is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Cancer.
Northeast Medical Group Inc
Jason Haldas is a Hematologist Oncology specialist and a Hematologist in Waterford, Connecticut. Dr. Haldas is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Anaplastic Large Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Immune ThrombocytopeniaDr. Johnson isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Breast CancerDr. Johnson isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Johnson isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Hemangioma Thrombocytopenia Syndrome
- Immune Thrombocytopenic Purpura (ITP)
- Inflammatory Breast CancerDr. Johnson isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Johnson isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Johnson isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Johnson isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Johnson isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Johnson isExperienced. Learn about Anemia.
- AngiosarcomaDr. Johnson isExperienced. Learn about Angiosarcoma.